Items Tagged ‘multiple sclerosis’

November 15, 2013

Mayo Clinic in the News Weekly Highlights

By Karl Oestreich Karl Oestreich (@KarlWOestreich)

    November 15, 2013 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media […]

View full entry

Tags: ABC News, Alexander Parker, alzheimers, American College of Gastroenterology, Atlanta Business Chronicle, Australian Broadcasting Corporation, back surgery, bacon, bacteria, bioethics, bird flu, Bjoerg Thorsteinsdottir


August 16, 2013

Mayo Clinic in the News Weekly Highlights

By Karl Oestreich Karl Oestreich (@KarlWOestreich)

    August 16, 2013 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media […]

View full entry

Tags: : ABC News Radio, 2 Minute Medicine, 9News Colo., ABC News, Alex Rodriguez, Almanac, Alyson Gonzalez, amenorrhea, American Academy of Sleep Medicine, American College of Cardiology's 62nd Annual Scientific Session, Arnold School of Public Health, Ashley Larkin


August 9, 2013

Mayo Clinic in the News Weekly Highlights

By Karl Oestreich Karl Oestreich (@KarlWOestreich)

    August 9, 2013 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media […]

View full entry

Tags: Almanac, alzheimer's disease, amyloid PET scans, biochemist, blocked heart arteries, Bloomberg, Cancer, cardiac care, cardiac rehabilitation, circulation, coronary artery bypass grafting, coronary artery bypass surgery


April 24, 2013

Mayo Clinic and Acorda Therapeutics Announce Initiation of Phase 1 Trial of Remyelinating Antibody in People with Multiple Sclerosis

By Logan Lafferty Logan Lafferty (@loganlafferty)

Mayo Clinic and Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the first patient has been enrolled in the first clinical trial of rHIgM22, a remyelinating antibody being studied for the treatment of multiple sclerosis (MS)… “This remyelinating antibody, if successful in clinical trials and approved, would be a novel approach to treating people with […]

View full entry

Tags: Acorda Therapeutics, antibody, chronic neurologic deficits, clinical trial, Dr. Moses Rodriguez, MS, multiple sclerosis, rHIgM22, Wall Street Journal


November 20, 2012

Mayo Clinic in the News Weekly Highlights

By Karl Oestreich Karl Oestreich (@KarlWOestreich)

    November 21, 2012 Mayo Clinic in the News is a weekly highlights summary of major media coverage. We are publishing on Wednesday this week because of the Thanksgiving holiday. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo […]

View full entry

Tags: Bloomberg, Business Courier Cincinnati, Cincinnati.com, Columbus Morning Call Business Journal, diabetes, Dr. Clayton Cowl, Dr. David Hayes, Dr. Eric Olson, Dr. James Levine, Dr. Kevin Reid, FOX 19 Cincinnati, FOX 9 Twin Cities


October 12, 2012

Early Study Looks Promising for MS-Like Illness

By Kelley Luckstein Kelley Luckstein (@KelleyLuckstein)

Mayo Clinic researchers say they were surprised by the success of an early study of a drug to treat a disease often misdiagnosed as multiple sclerosis. “It is very impressive, the results so far,'” said Dr. Sean Pittock, co-director of the clinic’s neuroimmunology laboratory. But he cautions the study is preliminary and needs confirmation, bigger […]

View full entry

Tags: Dr. Sean Pittock, drug study, multiple sclerosis, neuroimmunology, Post Bulletin


May 2, 2012

Neutralizing Enzyme Slows MS in Mice: Research

By Mystery User

U.S. researchers have discovered that neutralizing an enzyme can slow multiple sclerosis in mice. Scientists at the Mayo Clinic in Rochester, Minn., found the enzyme Kallikrein 6 was present in abundance in MS lesions and blood samples. As well, it is associated with inflammation and demyelination in other neurodegenerative diseases.   Edmonton Sun

View full entry

Tags: Edmonton Sun, Kallikrein 6, multiple sclerosis


March 29, 2010

Test Predicts Which Patients Benefit From $6 Billion MS Drugs

By Mystery User

Multiple sclerosis drugs from Biogen Idec Inc., Merck KGaA and Bayer AG with sales of $6.1 billion work for fewer than 3 in 4 patients and a test can predict which ones, a study found…   “This information could allow us to better select a group of people who are likely to respond in the […]

View full entry

Tags: Dean Wingerchuk, multiple sclerosis


December 18, 2009

Understanding MS is vital in controlling the disease

By Kelley Luckstein Kelley Luckstein (@KelleyLuckstein)

You may be familiar with multiple sclerosis. After all, an estimated 400,000 people, mostly adults, in the United States live with the disease. But did you know that more than twice as many women as men have MS?   According to Mayo Clinic neurologist Dr. Brian G. Weinshenker, women are more likely than men to […]

View full entry

Tags: multiple sclerosis


November 11, 2009

Mayo Clinic Neurologist Reports: “Thousands of NMO Patients are Misdiagnosed with

By Kelley Luckstein Kelley Luckstein (@KelleyLuckstein)

Thousands of Neuromyelitis Optica (NMO) patients are potentially being misdiagnosed with Multiple Sclerosis (MS), according to Mayo Clinic Neurologist Sean Pittock, M.D., largely due to lack of awareness of NMO within the medical community. Dr. Pittock shared this finding with more than 50 of the world’s leading doctors and medical researchers – from Harvard to […]

View full entry

Tags: multiple sclerosis, Neurology


Contact Us · Privacy Policy